Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option

The over-allotment option is being exercised in connection with Ampio's previously announced underwritten public offering of 4615400 shares of common stock, which was subsequently increased by 181250 shares to an aggregate of 4796650 such shares.
See all stories on this topic »